AMNEAL PHARMACEUTICALS (AMRX) Competitors $9.87 +0.09 (+0.92%) Closing price 04:00 PM EasternExtended Trading$9.82 -0.05 (-0.51%) As of 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AMRX vs. ASND, VTRS, RDY, MRNA, ROIV, QGEN, ELAN, BBIO, VRNA, and RVMDShould you be buying AMNEAL PHARMACEUTICALS stock or one of its competitors? The main competitors of AMNEAL PHARMACEUTICALS include Ascendis Pharma A/S (ASND), Viatris (VTRS), Dr. Reddy's Laboratories (RDY), Moderna (MRNA), Roivant Sciences (ROIV), QIAGEN (QGEN), Elanco Animal Health (ELAN), BridgeBio Pharma (BBIO), Verona Pharma PLC American Depositary Share (VRNA), and Revolution Medicines (RVMD). These companies are all part of the "pharmaceutical products" industry. AMNEAL PHARMACEUTICALS vs. Its Competitors Ascendis Pharma A/S Viatris Dr. Reddy's Laboratories Moderna Roivant Sciences QIAGEN Elanco Animal Health BridgeBio Pharma Verona Pharma PLC American Depositary Share Revolution Medicines AMNEAL PHARMACEUTICALS (NASDAQ:AMRX) and Ascendis Pharma A/S (NASDAQ:ASND) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, valuation, institutional ownership, dividends, analyst recommendations and profitability. Which has more risk & volatility, AMRX or ASND? AMNEAL PHARMACEUTICALS has a beta of 1.18, meaning that its share price is 18% more volatile than the S&P 500. Comparatively, Ascendis Pharma A/S has a beta of 0.41, meaning that its share price is 59% less volatile than the S&P 500. Do insiders and institutionals believe in AMRX or ASND? 31.8% of AMNEAL PHARMACEUTICALS shares are held by institutional investors. 26.6% of AMNEAL PHARMACEUTICALS shares are held by insiders. Comparatively, 40.0% of Ascendis Pharma A/S shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Do analysts recommend AMRX or ASND? AMNEAL PHARMACEUTICALS presently has a consensus target price of $12.00, indicating a potential upside of 21.58%. Ascendis Pharma A/S has a consensus target price of $248.29, indicating a potential upside of 19.93%. Given AMNEAL PHARMACEUTICALS's higher probable upside, equities analysts clearly believe AMNEAL PHARMACEUTICALS is more favorable than Ascendis Pharma A/S.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AMNEAL PHARMACEUTICALS 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80Ascendis Pharma A/S 1 Sell rating(s) 0 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 2.88 Does the media prefer AMRX or ASND? In the previous week, Ascendis Pharma A/S had 11 more articles in the media than AMNEAL PHARMACEUTICALS. MarketBeat recorded 13 mentions for Ascendis Pharma A/S and 2 mentions for AMNEAL PHARMACEUTICALS. Ascendis Pharma A/S's average media sentiment score of 0.83 beat AMNEAL PHARMACEUTICALS's score of 0.73 indicating that Ascendis Pharma A/S is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AMNEAL PHARMACEUTICALS 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Ascendis Pharma A/S 7 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Is AMRX or ASND more profitable? AMNEAL PHARMACEUTICALS has a net margin of 0.12% compared to Ascendis Pharma A/S's net margin of -54.94%. Ascendis Pharma A/S's return on equity of 0.00% beat AMNEAL PHARMACEUTICALS's return on equity.Company Net Margins Return on Equity Return on Assets AMNEAL PHARMACEUTICALS0.12% -189.49% 6.17% Ascendis Pharma A/S -54.94%N/A -24.31% Which has preferable valuation and earnings, AMRX or ASND? AMNEAL PHARMACEUTICALS has higher revenue and earnings than Ascendis Pharma A/S. Ascendis Pharma A/S is trading at a lower price-to-earnings ratio than AMNEAL PHARMACEUTICALS, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAMNEAL PHARMACEUTICALS$2.79B1.11-$116.89M$0.01987.00Ascendis Pharma A/S$393.54M32.45-$409.12M-$5.16-40.12 SummaryAMNEAL PHARMACEUTICALS beats Ascendis Pharma A/S on 9 of the 16 factors compared between the two stocks. Get AMNEAL PHARMACEUTICALS News Delivered to You Automatically Sign up to receive the latest news and ratings for AMRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AMRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AMRX vs. The Competition Export to ExcelMetricAMNEAL PHARMACEUTICALSMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.07B$2.64B$6.10B$10.55BDividend YieldN/A57.78%5.73%4.78%P/E Ratio987.994.9863.4322.98Price / Sales1.11774.25604.86133.16Price / Cash7.04175.9337.8662.13Price / Book-28.205.4112.396.65Net Income-$116.89M$33.06M$3.32B$276.79M7 Day Performance-4.08%-2.27%-0.24%-1.51%1 Month Performance1.33%11.49%9.56%5.45%1 Year Performance13.45%-3.25%71.67%36.24% AMNEAL PHARMACEUTICALS Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AMRXAMNEAL PHARMACEUTICALS3.5113 of 5 stars$9.87+0.9%$12.00+21.6%+11.0%$3.07B$2.79B987.998,100ASNDAscendis Pharma A/S2.6597 of 5 stars$210.83+3.3%$244.36+15.9%+62.7%$12.59B$393.54M-40.861,017News CoverageAnalyst ForecastAnalyst RevisionHigh Trading VolumeVTRSViatris3.044 of 5 stars$10.13-0.6%$10.40+2.7%-15.7%$11.88B$14.74B-3.4932,000News CoveragePositive NewsAnalyst ForecastRDYDr. Reddy's Laboratories3.0814 of 5 stars$14.12-0.3%$16.95+20.0%-11.0%$11.82B$3.81B21.3927,811News CoverageMRNAModerna4.2364 of 5 stars$27.54-3.3%$41.81+51.8%-51.6%$11.08B$3.24B-3.665,800ROIVRoivant Sciences2.9843 of 5 stars$16.26+0.6%$19.94+22.6%+43.0%$11.04B$29.05M-23.23860Insider TradeQGENQIAGEN4.1029 of 5 stars$46.99+0.4%$49.40+5.1%+11.5%$10.40B$1.98B27.765,765ELANElanco Animal Health2.4968 of 5 stars$20.68+0.2%$18.33-11.3%+47.1%$10.25B$4.44B24.059,000Analyst RevisionBBIOBridgeBio Pharma4.4392 of 5 stars$54.61+3.3%$63.94+17.1%+123.1%$10.11B$221.90M-13.35400Analyst RevisionVRNAVerona Pharma PLC American Depositary Share1.5375 of 5 stars$106.91+0.1%$109.00+2.0%N/A$9.20B$42.28M-107.9930Positive NewsRVMDRevolution Medicines4.2597 of 5 stars$46.58-0.3%$74.64+60.2%+1.2%$8.73B$11.58M-10.35250News CoverageAnalyst ForecastInsider Trade Related Companies and Tools Related Companies ASND Competitors VTRS Competitors RDY Competitors MRNA Competitors ROIV Competitors QGEN Competitors ELAN Competitors BBIO Competitors VRNA Competitors RVMD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AMRX) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredWhite House Letter Reveals “MAGA’s Master Plan”If you thought tariffs were big news, the next phase of MAGA’s economic plan could be far more transformative ...StocksToTrade | SponsoredWall St’s “AI Godfather” breaks his silenceWhats next after AI? Hidden AI. "Hidden AI" could soon be the biggest investment trend of 2025.Chaikin Analytics | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AMNEAL PHARMACEUTICALS, INC. Please log in to your account or sign up in order to add this asset to your watchlist. Share AMNEAL PHARMACEUTICALS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
